Exosomes derived from TNF-α-treated bone marrow mesenchymal stem cells ameliorate myocardial infarction injury in mice

References

• Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197–10. doi:10.1016/S0140-6736(16)30677-8.
   PubMed Web of Science ®Google Scholar
• Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, Shohaimi S, Mohammadi M. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23(1):206. doi:10.1186/s12872-023-03231-w.
   PubMedGoogle Scholar
• Wu M, Wang W, Zhang X, Li J. The prevalence of acute stress disorder after acute myocardial infarction and its psychosocial risk factors among young and middle-aged patients. Sci Rep. 2022;12(1):7675. doi:10.1038/s41598-022-11855-9.
   PubMedGoogle Scholar
• Fioretta ES, Motta SE, Lintas V, Loerakker S, Parker KK, Baaijens FPT, Falk V, Hoerstrup SP, Emmert MY. Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity. Nat Rev Cardiol. 2021;18(2):92–116. doi:10.1038/s41569-020-0422-8.
   PubMed Web of Science ®Google Scholar
• Belien H, Evens L, Hendrikx M, Bito V, Bronckaers A. Combining stem cells in myocardial infarction: the road to superior repair? Med Res Rev. 2022;42(1):343–73. doi:10.1002/med.21839.
   PubMed Web of Science ®Google Scholar
• Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012;(2):CD006536. doi:10.1002/14651858.CD006536.pub3.
   PubMed Web of Science ®Google Scholar
• Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015;2015(9):CD006536. doi:10.1002/14651858.CD006536.pub4.
   PubMedGoogle Scholar
• Cai M, Shen R, Song L, Lu M, Wang J, Zhao S, Tang Y, Meng X, Li Z, He ZX. Bone Marrow Mesenchymal Stem Cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects. Sci Rep. 2016;6(1):28250. doi:10.1038/srep31528.
   PubMedGoogle Scholar
• Miao C, Lei M, Hu W, Han S, Wang Q. A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction. Stem Cell Res Ther. 2017;8(1):242. doi:10.1186/s13287-017-0697-9.
   PubMedGoogle Scholar
• Yamada Y, Minatoguchi S, Kanamori H, Mikami A, Okura H, Dezawa M, Minatoguchi S. Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells. J Cardiol. 2022;80(1):80–87. doi:10.1016/j.jjcc.2021.10.030.
   PubMed Web of Science ®Google Scholar
• Krause M, Samoylenko A, Vainio SJ. Exosomes as renal inductive signals in health and disease, and their application as diagnostic markers and therapeutic agents. Front Cell Dev Biol. 2015;3:65. doi:10.3389/fcell.2015.00065.
   PubMed Web of Science ®Google Scholar
• Ala M. The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy. Ageing Res Rev. 2023;89:101980. doi:10.1016/j.arr.2023.101980.
   PubMed Web of Science ®Google Scholar
• Burke J, Kolhe R, Hunter M, Isales C, Hamrick M, Fulzele S. Stem cell-derived exosomes: a potential alternative therapeutic agent in orthopaedics. Stem Cells Int. 2016;2016:1–6. doi:10.1155/2016/5802529.
   Web of Science ®Google Scholar
• Charles CJ, Li RR, Yeung T, Mazlan SMI, Lai RC, de Kleijn DPV, Lim SK, Richards AM. Systemic mesenchymal stem cell-derived exosomes reduce myocardial infarct size: characterization with MRI in a porcine model. Front Cardiovasc Med. 2020;7. doi:10.3389/fcvm.2020.601990.
   PubMed Web of Science ®Google Scholar
• Wang S, Dong J, Li L, Wu R, Xu L, Ren Y, Hu X. Exosomes derived from miR-129-5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction. J Tissue Eng Regen Med. 2022;16(2):177–87. doi:10.1002/term.3268.
   PubMed Web of Science ®Google Scholar
• Das CK, Jena BC, Banerjee I, Das S, Parekh A, Bhutia SK, Mandal M. Exosome as a novel shuttle for delivery of therapeutics across biological barriers. Mol Pharm. 2019;16(1):24–40. doi:10.1021/acs.molpharmaceut.8b00901.
   PubMedGoogle Scholar
• Batrakova EV, Kim MS. Development and regulation of exosome-based therapy products. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8(5):744–57. doi:10.1002/wnan.1395.
   PubMed Web of Science ®Google Scholar
• Ilaltdinov AW, Gong Y, Leong DJ, Gruson KI, Zheng D, Fung DT, Sun L, Sun HB. Advances in the development of gene therapy, noncoding RNA, and exosome-based treatments for tendinopathy. Ann N Y Acad Sci. 2021;1490(1):3–12. doi:10.1111/nyas.14382.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307. doi:10.3390/cells8040307.
   PubMed Web of Science ®Google Scholar
• Zhao R, Zhao T, He Z, Cai R, Pang W. Composition, isolation, identification and function of adipose tissue-derived exosomes. Adipocyte. 2021;10(1):587–604. doi:10.1080/21623945.2021.1983242.
   PubMed Web of Science ®Google Scholar
• Heo JS, Choi Y, Kim HO. Adipose-derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes. Stem Cells Int. 2019;2019:1–10. doi:10.1155/2019/7921760.
   Web of Science ®Google Scholar
• Li YW, Zhang C, Sheng QJ, Bai H, Ding Y, Dou XG. Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages. World J Gastroenterol. 2017;23(45):7978–88. doi:10.3748/wjg.v23.i45.7978.
   PubMed Web of Science ®Google Scholar
• Hu H, Wu J, Cao C, Ma L. Exosomes derived from regulatory T cells ameliorate acute myocardial infarction by promoting macrophage M2 polarization. Lubmb Life. 2020;72(11):2409–19. doi:10.1002/iub.2364.
   PubMed Web of Science ®Google Scholar
• Ning H, Chen H, Deng J, Xiao C, Xu M, Shan L, Yang C, Zhang Z. Exosomes secreted by FNDC5-BMMSCs protect myocardial infarction by anti-inflammation and macrophage polarization via NF-kappaB signaling pathway and Nrf2/HO-1 axis. Stem Cell Res Ther. 2021;12(1):519. doi:10.1186/s13287-021-02591-4.
   PubMed Web of Science ®Google Scholar
• Xu H, Fu J, Chen L, Zhou S, Fang Y, Zhang Q, Chen X, Yuan L, Li Y, Xu Z. et al. TNF-α enhances the therapeutic effects of MenSC-derived small extracellular vesicles on inflammatory bowel disease through macrophage polarization by miR-24-3p. Stem Cells Int. 2023;2023:1–28. doi:10.1155/2023/2988907.
   Web of Science ®Google Scholar
• Maridas DE, Rendina-Ruedy E, Le PT, Rosen CJ. Isolation, culture, and differentiation of bone marrow stromal cells and osteoclast progenitors from mice. J Vis Exp. 2018;131:e56750. doi:10.3791/56750.
   Google Scholar
• Borst O, Ochmann C, Schonberger T, Jacoby C, Stellos K, Seizer P, Flogel U, Lang F, Gawaz M. Methods employed for induction and analysis of experimental myocardial infarction in mice. Cell Physiol Biochem. 2011;28(1):1–12. doi:10.1159/000331708.
   PubMedGoogle Scholar
• Choi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, Linden DR, Szurszewski JH, Gibbons SJ. et al. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology. 2010;138(7):2399–409.e1. doi:10.1053/j.gastro.2010.02.014.
   PubMed Web of Science ®Google Scholar
• Baudouy D, Michiels JF, Vukolic A, Wagner KD, Wagner N. Echocardiographic and histological examination of cardiac morphology in the mouse. J Vis Exp. 2017;2017(128):e55843. doi:10.3791/55843-v.
   Google Scholar
• Wang L, Zhang W, Cen R, Yue C, Xiao T, Deng Y, Li L, Sun K, Lei X. ALA-PDT regulates macrophage M1 polarization via ERK/MAPK-NLRP3 pathway to promote the early inflammatory response. Lasers Surg Med. 2022;54(10):1309–20. doi:10.1002/lsm.23618.
   PubMed Web of Science ®Google Scholar
• Zhu F, Chen Y, Li J, Yang Z, Lin Y, Jiang B, Shao L, Hu S, Shen Z. Human umbilical cord mesenchymal stem cell-derived exosomes attenuate myocardial infarction injury via miR-24-3p-promoted M2 macrophage polarization. Adv Biol (Weinh). 2022;6(11):e2200074. doi:10.1002/adbi.202200074.
   PubMedGoogle Scholar
• Gonzalez A, Ravassa S, Beaumont J, Lopez B, Diez J. New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol. 2011;58(18):1833–43. doi:10.1016/j.jacc.2011.06.058.
   PubMed Web of Science ®Google Scholar
• Huang L, Ran L, Zhao P, Tang D, Han R, Ai T, Xia L, Tao Q. MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes. Br J Radiol. 2019;92(1104):20190634. doi:10.1259/bjr.20190634.
   PubMed Web of Science ®Google Scholar
• Kim Y, Nurakhayev S, Nurkesh A, Zharkinbekov Z, Saparov A. Macrophage polarization in cardiac tissue repair following myocardial infarction. Int J Mol Sci. 2021;22(5):2715. doi:10.3390/ijms22052715.
   PubMed Web of Science ®Google Scholar
• Mouton AJ, DeLeon-Pennell KY, Rivera Gonzalez OJ, Flynn ER, Freeman TC, Saucerman JJ, Garrett MR, Ma Y, Harmancey R, Lindsey ML. Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol. 2018;113(4):26. doi:10.1007/s00395-018-0686-x.
   PubMed Web of Science ®Google Scholar
• Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, Lindsey ML. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112(3):33. doi:10.1007/s00395-017-0622-5.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang X, Zhao M, Zhang X, Chi J, Liu Y, Lin F, Fu Y, Ma D, Yin X. Activation in M1 but not M2 macrophages contributes to cardiac remodeling after myocardial infarction in rats: a critical role of the calcium sensing receptor/NRLP3 inflammasome. Cell Physiol Biochem. 2015;35(6):2483–500. doi:10.1159/000374048.
   PubMedGoogle Scholar